TrialBlood advances2022

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.

Aimee C Talleur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.